MATTHEW SIMMONS: Open Payments
NPI 1326165572 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 42 payments from 7 companies in 2025. Trend: 2023 $534 · 2024 $519 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $419 |
| Gilead Sciences, Inc. | 3 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| PFIZER INC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: RINVOQ, Livdelzi, SKYRIZI, ENTYVIO, LINZESS, ZENPEP, XELJANZ, DUPIXENT.
Industry payments across FL — which companies pay providers there.
